The weekly litigation news digest is live. Subscribe now

IP Verse

Improved Recombinant Human Follicle-Stimulating Hormone - EP3075744

The patent EP3075744 was granted to Glycotope on Dec 18, 2019. The application was originally filed on Aug 4, 2011 under application number EP16168841A. The patent is currently recorded with a legal status of "Revoked".

EP3075744

GLYCOTOPE
Application Number
EP16168841A
Filing Date
Aug 4, 2011
Status
Revoked
Aug 6, 2021
Publication Date
Dec 18, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AUGUST DEBOUZYSep 11, 2020AUGUST DEBOUZY -

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP20090014585
DESCRIPTIONWO2011063943
OPPOSITIONWO2008028686
OPPOSITIONWO2009127826
OTHERWO2008028686
OTHERWO2009127826
SEARCHWO03035686
SEARCHWO2009127826

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents